Table of Contents
Journal of Biomarkers
Volume 2015 (2015), Article ID 841245, 9 pages
http://dx.doi.org/10.1155/2015/841245
Research Article

Biomarkers for Detection and Monitoring of B16 Melanoma in Mouse Urine and Feces

1Department of Biomedical Engineering, Ben-Gurion University of the Negev, 84105 Beer-Sheva, Israel
2The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, and the Department of Oncology, Soroka University Medical Center, 84105 Beer-Sheva, Israel
3Division of Chemistry, Nuclear Research Center-Negev, 84190 Beer-Sheva, Israel

Received 29 September 2014; Revised 1 January 2015; Accepted 29 January 2015

Academic Editor: Nathalie Scholler

Copyright © 2015 Aviv Sever et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Cancer Society, Cancer Facts & Figures 2014, American Cancer Society, Atlanta, Ga, USA, 2014.
  2. D. S. Rigel, J. Russak, and R. Friedman, “The evolution of melanoma diagnosis: 25 years beyond the ABCDs,” CA—Cancer Journal for Clinicians, vol. 60, no. 5, pp. 301–316, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Shirasu and K. Touhara, “The scent of disease: volatile organic compounds of the human body related to disease and disorder,” Journal of Biochemistry, vol. 150, no. 3, pp. 257–266, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Williams and A. Pembroke, “Sniffer dogs in the melanoma clinic?” The Lancet, vol. 1, no. 8640, article 734, 1989. View at Google Scholar · View at Scopus
  5. D. Pickel, G. P. Manucy, D. B. Walker, S. B. Hall, and J. C. Walker, “Evidence for canine olfactory detection of melanoma,” Applied Animal Behaviour Science, vol. 89, no. 1-2, pp. 107–116, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. A. D'amico, R. Bono, G. Pennazza et al., “Identification of melanoma with a gas sensor array,” Skin Research and Technology, vol. 14, no. 2, pp. 226–236, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Abaffy, M. Moller, D. D. Riemer, C. Milikowski, and R. A. Defazio, “A case report—volatile metabolomic signature of malignant melanoma using matching skin as a control,” Journal of Cancer Science & Therapy, vol. 3, no. 6, pp. 140–144, 2011. View at Google Scholar
  8. J. Kwak, M. Gallagher, M. H. Ozdener et al., “Volatile biomarkers from human melanoma cells,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 931, pp. 90–96, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. A. Menendez and R. Lupu, “Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis,” Nature Reviews Cancer, vol. 7, no. 10, pp. 763–777, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Hakim, Y. Y. Broza, O. Barash et al., “Volatile organic compounds of lung cancer and possible biochemical pathways,” Chemical Reviews, vol. 112, no. 11, pp. 5949–5966, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Xue, L. Dong, S. Zhang et al., “Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry,” Rapid Communications in Mass Spectrometry, vol. 22, no. 8, pp. 1181–1186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Hanai, K. Shimono, H. Oka, Y. Baba, K. Yamazaki, and G. K. Beauchamp, “Analysis of volatile organic compounds released from human lung cancer cells and from the urine of tumor-bearing mice,” Cancer Cell International, vol. 12, article 7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Matsumura, M. Opiekun, H. Oka et al., “Urinary volatile compounds as biomarkers for lung cancer: a proof of principle study using odor signatures in mouse models of lung cancer,” PLoS ONE, vol. 5, no. 1, Article ID e8819, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Shao, “Linear model selection by cross-validation,” Journal of the American Statistical Association, vol. 88, no. 422, pp. 486–494, 1993. View at Publisher · View at Google Scholar · View at MathSciNet
  15. A. Zwielly, J. Gopas, G. Brkic, and S. Mordechai, “Discrimination between drug-resistant and non-resistant human melanoma cell lines by FTIR spectroscopy,” Analyst, vol. 134, no. 2, pp. 294–300, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Zwielly, S. Mordechai, G. Brkic et al., “Grading of intrinsic and acquired cisplatin-resistant human melanoma cell lines: an infrared ATR study,” European Biophysics Journal, vol. 40, no. 6, pp. 795–804, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. E. Stein, “Chemical substructure identification by mass spectral library searching,” Journal of the American Society for Mass Spectrometry, vol. 6, no. 8, pp. 644–655, 1995. View at Publisher · View at Google Scholar · View at Scopus